Titration

Immuno Oncology Assays Market worth $7.9 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, April 22, 2021

The consumables segment accounted for the largest share of the market in 2020.

Key Points: 
  • The consumables segment accounted for the largest share of the market in 2020.
  • Unlike instruments, consumables require repeat purchase, which results in their stable demand among end users.\nThe immuno-oncology assays market is segmented into PCR, immunoassay, NGS, flow cytometry, and ISH based on technology.
  • In 2020, the research applications segment accounted for the largest share of the market.
  • The emergence of cancer immunotherapy is driving this segments growth.\nThe immuno-oncology assays market is segmented into five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Immuno Oncology Assays Market worth $7.9 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, April 22, 2021

The consumables segment accounted for the largest share of the market in 2020.

Key Points: 
  • The consumables segment accounted for the largest share of the market in 2020.
  • Unlike instruments, consumables require repeat purchase, which results in their stable demand among end users.\nThe immuno-oncology assays market is segmented into PCR, immunoassay, NGS, flow cytometry, and ISH based on technology.
  • In 2020, the research applications segment accounted for the largest share of the market.
  • The emergence of cancer immunotherapy is driving this segments growth.\nThe immuno-oncology assays market is segmented into five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Oxidative Stress Assay Market worth $1326 million by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, April 13, 2021

b'The growth of this market is mainly driven by growth in the biopharmaceutical industry and increasing public-sector funding for academic research.

Key Points: 
  • b'The growth of this market is mainly driven by growth in the biopharmaceutical industry and increasing public-sector funding for academic research.
  • On the other hand, the high cost of instruments and shortage of trained and qualified personnel are the major factors restraining the growth of this market.\nThe consumables segment accounted for the largest share of the oxidative stress assay market, by product, in 2020.\nOn the basis of product, the oxidative stress assay market is segmented into consumables, instruments, and services.
  • This segment is also projected to register the highest CAGR from 2020 to 2025.
  • Pharmaceutical and biotechnology companies are the largest end users of oxidative stress assays.

Oxidative Stress Assay Market worth $1326 million by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, April 13, 2021

b'The growth of this market is mainly driven by growth in the biopharmaceutical industry and increasing public-sector funding for academic research.

Key Points: 
  • b'The growth of this market is mainly driven by growth in the biopharmaceutical industry and increasing public-sector funding for academic research.
  • On the other hand, the high cost of instruments and shortage of trained and qualified personnel are the major factors restraining the growth of this market.\nThe consumables segment accounted for the largest share of the oxidative stress assay market, by product, in 2020.\nOn the basis of product, the oxidative stress assay market is segmented into consumables, instruments, and services.
  • This segment is also projected to register the highest CAGR from 2020 to 2025.
  • Pharmaceutical and biotechnology companies are the largest end users of oxidative stress assays.

Proactive news headlines including Australian Potash, Jindalee Resources, Kazia Therapeutics and Latin Resources

Retrieved on: 
Friday, April 9, 2021

Click here

Key Points: 
  • Click here
    Latin Resources Ltd (ASX:LRS) (FRA:XL5) ongoing test results from the Noombenberry Project in Western Australia are showing some of the highest grade halloysite and kaolin assays in Australia, including a 41% halloysite assay.
  • Our written and video content is published on Proactive sites that collectively attract up to 10 million views per month.
  • We help the world understand what makes companies stand out from the crowd with in-depth investment research from a team of experienced analysts.
  • For more information on how Proactive can help you make a difference, email us at [email protected]

Global Cell-Based Assays Markets Report 2021-2026: Opportunities in the Growing Risk of Pandemics and Communicable Diseases & Application of Novel Cell-Based Assays in Cancer Research

Retrieved on: 
Tuesday, April 6, 2021

The growing preference for cell-based assays in drug discovery, increasing funding for cell-based research, and growth in the number of drug discovery activities are the key factors supporting the growth of the market.

Key Points: 
  • The growing preference for cell-based assays in drug discovery, increasing funding for cell-based research, and growth in the number of drug discovery activities are the key factors supporting the growth of the market.
  • In this report, the cell-based assays market has been segmented based on product and service, application, end-user, and region.
  • By product and service, the consumables segment accounted for the largest share of the cell-based assays market.
  • The cell-based assays market is categorized into major three product and service categories, consumables, instrument & software and services.

Biocept to Host Key Opinion Leader Webinar on April 8 to Discuss its CSF Assay for the Diagnosis of Cancer Involving the Central Nervous System

Retrieved on: 
Thursday, April 1, 2021

Nicholas Blondin, MD is Assistant Professor of Clinical Neurology at Yale School of Medicine.

Key Points: 
  • Nicholas Blondin, MD is Assistant Professor of Clinical Neurology at Yale School of Medicine.
  • Dr. Blondin is an active investigator for clinical trials for brain tumor patients through Yale Cancer Center.
  • In addition to its broad portfolio of blood-based liquid biopsy assays, Biocept is developing and commercializing its cerebrospinal fluid (CSF) assay that detects cancer that has metastasized to the central nervous system.
  • The Companys CSF assay identifies molecular targets for clinical decision making and provides quantitative information for monitoring treatment response.

$14.9 Bn Cell-Based Assays Market by Product & Service (Reagents, Microplate, Cell Lines, Assay Kits, Instrument & Software, Services), Application (Drug Discovery, Research) - Global Forecast to 2025 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 30, 2021

The cell-based assays market is projected to reach USD 22.0 billion by 2025 from USD 14.9 billion in 2020, at a CAGR of 8.1% during the forecast period.

Key Points: 
  • The cell-based assays market is projected to reach USD 22.0 billion by 2025 from USD 14.9 billion in 2020, at a CAGR of 8.1% during the forecast period.
  • In this report, the cell-based assays market has been segmented based on product and service, application, end-user, and region.
  • By product and service, the consumables segment accounted for the largest share of the cell-based assays market.
  • The cell-based assays market is categorized into major three product and service categories, consumables, instrument & software and services.

New Found Intercepts 51.3 g/t Au over 3.20m and 53.3 g/t Au over 3.10m in Step-outs to Depth at Lotto

Retrieved on: 
Tuesday, March 23, 2021

Assays are uncut, and calculated intervals are reported over a minimum length of 2 meters using a lower cutoff of 1.0 g/t Au.

Key Points: 
  • Assays are uncut, and calculated intervals are reported over a minimum length of 2 meters using a lower cutoff of 1.0 g/t Au.
  • Standards and blanks are included with every 20 samples for Quality Assurance/Quality Control purposes by the Company as well as the lab.
  • New Found acknowledges the financial support of the Junior Exploration Assistance Program, Department of Natural Resources, Government of Newfoundland and Labrador.
  • To contact the Company, please visit the Company's website, www.newfoundgold.ca and make your request through our investor inquiry form.

Cell-based Assays Market worth $22.0 billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, March 19, 2021

Based on product and service, the market is segmented into consumables, instruments & software, and services.

Key Points: 
  • Based on product and service, the market is segmented into consumables, instruments & software, and services.
  • Based on application, the cell based assays market is categorized into drug discovery, basic research, and other applications.
  • Based on end users, the cell based assays market is segmented into pharmaceutical & biopharmaceutical companies, academic & research institutes, and contract research organizations (CROs).
  • The cell-based assays market is segmented into North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), and the Middle East and Africa (MEA).